Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2008 Results
Date:10/30/2008

vandapharma.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Various statements in this release are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," and "could," and similar expressions or words, identify forward- looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Vanda is at an early stage of development and may not ever have any products that generate significant revenue. Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: delays in the completion of Vanda's clinical trials; a failure of Vanda's product candidates to be demonstrably safe and effective; Vanda's failure to obtain regulatory approval for its products or to comply with ongoing regulatory requirements; a lack of acceptance of Vanda's product candidates in the marketplace, or a failure to become or remain profitable; Vanda's inability to obtain the capital necessary to fund its research and development activities; Vanda's failure to identify or obtain rights to new product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products under its license and sublicense agreements and other factors that are described in the "Risk Factors" section (Part II, Item 1A) of Vanda's quarterly report on Form 10-Q for the quarter ended June 30, 2008 (File No. 000-51863). In addition to the risks described above and in Part II, Item 1A of Vanda's quarterly report on F
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 BerGenBio AS ... announces that an abstract on the latest data on ... the Axl receptor tyrosine kinase, and BGB10C9, an Axl ... been published in conjunction with the 2015 American Society ... Chicago , May 29 - June 2, 2015. ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The Academy ... to thirteen high school graduates from across the nation. ... created to award qualified AMA Youth Members with scholarships ... the AMA Scholarship Program has awarded nearly $900,000 to ... by model aviation organizations and individuals, AMA member donations, ...
(Date:5/29/2015)... London, UK (PRWEB) May 29, 2015 ... Co., Ltd. (Chem-Report ) signed a partnership agreement ... is now authorised to distribute and sell research ... Assistant Manager at Partners Department, commented upon the ... creating reports on key petroleum and chemical markets ...
(Date:5/29/2015)... When a leading manufacturer of ... to design an industrial oven that ... being produced using a 3D-printing process, Gruenberg engineers ... gantry, heat-saving windows, and internal actuators and sensors ... pills to exact specifications. , To ensure the ...
Breaking Biology Technology:BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Academy of Model Aeronautics Awards $46,500 in Scholarships to College-Bound Model Aviation Pilots 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3New industrial oven with “pill pushing” robotic gantry precisely removes excess moisture from 3D-printed pharmaceuticals 2
... a healthcare,technology company, announced today they have ... to a 10 year contract. The Canadian ... benefits and claims,solution and its integrated AboveHealth(R) ... medical, dental, life, disability and,pharmacy lines of ...
... Corporation,(Nasdaq: NEOG ) announced today that it ... and hygiene applications from DuPont Animal Health Solutions,(DAHS). ... with manufacturing process know-how and associated registration,information. The ... The addition of these products to Neogen,s Animal ...
... 1 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced ... BioMarin, will present a,company update at the Collins Stewart ... 2008 at 9:30 a.m. ET., Interested parties may ... investor section of the BioMarin website, http://www.BMRN.com . ...
Cached Biology Technology:Healthation Chosen by Large Canadian Third Party Administrator to Support All Employee Benefits and Claims Administration 2Neogen Acquires Product Line From DuPont Animal Health Solutions 2BioMarin to Present at the Collins Stewart Growth Conference 2
(Date:5/26/2015)... 26, 2015 Research and ... of the "Saudi Arabia Biometric Systems Market ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems ... is projected to grow at over 22% CAGR ... attributed to the surging demand for better biometric ...
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/21/2015)... , May 21, 2015 ... Imaging Market by Solutions (Hardware, Software, Services), by Applications ... & others), by End-Users (Military & Defense & ... MarketsandMarkets, Thermal Imaging Market is expected to grow ... by 2020, at a Compound Annual Growth Rate ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4
... researchers at the National Institute of Environmental Health Sciences (NIEHS), ... women who binge drink early in their pregnancy increase the ... The researchers found that women who consumed an average ... twice as likely than non-drinkers to have an infant with ...
... scientists at the National High Magnetic Field Laboratory at ... petroleum companies to locate, analyze and process crude oil ... Marshall, a giant in the field of chemical analysis, ... with a California-based company, Sierra Analytics ( www.MassSpec.com ), ...
... water and nutrients from its plant host also taps into ... lead to new ways to combat parasites that attack crop ... Davis Section of Plant Biology studied dodder vines growing on ... from the host could be found in the dodder up ...
Cached Biology News:Alcohol binges early in pregnancy increase risk of infant oral clefts 2FSU, Magnet Lab researchers license critical petroleum data 2
... by A300-183A maps to the ... human quaking homolog according to ... The epitope is not found ... 4, 6, 7 or 7B ...
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
...
... [198C679.2.1] to Presenilin 2 Alzheimer's disease ... the disease carry mutations in the presenilin ... protein (APP). These disease-linked mutations result in ... amyloid-beta (main component of amyloid deposits found ...
Biology Products: